Results 121 to 130 of about 8,272 (178)

A mouse model of cardiac immunoglobulin light chain amyloidosis reveals insights into tissue accumulation and toxicity of amyloid fibrils. [PDF]

Nat Commun
Martinez-Rivas G, Ayala MV, Bender S, Codo GR, Swiderska WK, Lampis A, Pedroza L, Merdanovic M, Sicard P, Pinault E, Richard L, Lavatelli F, Giorgetti S, Canetti D, Rinsant A, Kaaki S, Ory C, Oblet C, Pollet J, Naser E, Carpinteiro A, Roussel M, Javaugue V, Jaccard A, Bonaud A, Delpy L, Ehrmann M, Bridoux F, Sirac C.   +28 more
europepmc   +1 more source

The clinical trials landscape in immunoglobulin light chain amyloidosis: a systematic review. [PDF]

Blood Adv
Ramachandran R, Shah D, Luo C, Shah V, Cliff ERS, Sanchorawala V, Lentzsch S, Chakraborty R.   +7 more
europepmc   +1 more source

Venetoclax Plus CyBorD Induction Therapy and Venetoclax Maintenance Treatment for Immunoglobulin Light Chain Amyloidosis with t(11;14) Translocation. [PDF]

Curr Oncol
Garami G, Obajed Al-Ali O, Virga I, Gulyás A, Bedekovics J, Tornai I, Illés Á, Magyari F.   +7 more
europepmc   +1 more source

Intraoral hemorrhagic bullae as the first sign of immunoglobulin light chain amyloidosis. [PDF]

CMAJ
Dominguez-Lopez RM, Naharro-Rodriguez J.
europepmc   +1 more source

Prognostic factors in Chinese patients with immunoglobulin light chain amyloidosis: a scoping review and meta-analysis. [PDF]

Ann Med
Wu Y, Wang X, Gào X, Xu L, Wang B, Cai Z.   +5 more
europepmc   +1 more source

Case Report: A missed diagnosis of cardiac amyloidosis using echocardiography due to immunoglobulin light chain amyloidosis with normal wall thickness in the early stage. [PDF]

Front Cardiovasc Med
Li X, Mu T, Deng Y, Zhang Y, Ti Y, Zhang L.   +5 more
europepmc   +1 more source

Venetoclax in Immunoglobulin Light Chain Amyloidosis: Is This the Beginning or the End? [PDF]

Clin Lymphoma Myeloma Leuk, 2019
Premkumar V, Comenzo R, Lentzsch S.
europepmc   +1 more source

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis. [PDF]

Blood Cancer J, 2020
Warsame R, LaPlant B, Kumar SK, Laumann K, Perez Burbano G, Buadi FK, Gertz MA, Kyle RA, Lacy MQ, Dingli D, Leung N, Hayman SR, Kapoor P, Hwa YL, Fonder A, Hobbs M, Gonsalves WI, Kourelis T, Lust J, Russell SJ, Zeldenrust S, Lin Y, Muchtar E, Go RS, Vincent Rajkumar S, Dispenzieri A.   +25 more
europepmc   +1 more source

Characterization, outcome and identification of prognostic factors for patients with systemic immunoglobulin lightchain amyloidosis requiring dialysis prior to initial anticlonal therapy. [PDF]

Haematologica
Sester LS, Milani P, Theodorakakou F, Dittrich T, Beimler J, Aus dem Siepen F, Zeier M, Raab MS, Müller-Tidow C, Kastritis E, Palladini G, Hegenbart U, Schönland SO.   +12 more
europepmc   +1 more source

AMYLOID GOITER AS THE FIRST RECOGNIZABLE MANIFESTATION OF IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS. [PDF]

AACE Clin Case Rep, 2019
Orrego JJ, Chorny JA.
europepmc   +1 more source